Icu Medical Inc. (ICUI)
NASDAQ
Closed
Aug 24, 2026
Day's Range
180.2652 wk Range
112.50Overview - ICUI - Icu Medical Inc.
Key Statistics
Valuation
Enterprise Value
5.55B
P/E (Trailing)
‪153.64‬
P/E (Forward)
‪18.95‬
PEG Ratio
‪-3.27‬
Price / Sales (TTM)
‪2.11‬
Price / Book
‪2.12‬
EV / EBITDA
‪17.03‬
Profitability
Gross Margin
‪42.60%‬
Profit Margin
‪1.39%‬
Operating Margin
‪7.52%‬
Return on Assets
‪1.93%‬
Return on Equity
‪1.40%‬
Ownership
Shares Outstanding
24.99M
Float
24.53M
Short % of Shares Outstanding
‪6.64%‬
Held by Insiders
‪1.83%‬
Held by Institutions
‪116.25%‬
Price stats
Beta
‪0.75‬
50-Day Avg
‪160.63‬
200-Day Avg
‪143.66‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
8 analysts
Average price target
‪$ 193.38‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ICUI - Icu Medical Inc.
Peers - ICUI - Icu Medical Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - ICUI - Icu Medical Inc.
About
ICU Medical Inc. is a medical technology company that develops, manufactures, and sells innovative medical devices for infusion therapy, vascular access, and vital care applications worldwide. Its product portfolio spans three key business segments: Consumables, featuring infusion sets, vascular access products, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
